1 – 5 of 147
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
(
- Contribution to journal › Article
-
Mark
Long-Term Oxygen Therapy for 24 or 15 Hours per Day in Severe Hypoxemia
(
- Contribution to journal › Article
-
Mark
Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer
(
- Contribution to journal › Article
- 2023
-
Mark
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
(
- Contribution to journal › Letter
-
Mark
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B
(
- Contribution to journal › Article